News

Portfolio Companies
in the News

Medtronic inks distribution deal with Contego with option to buy firm

January 13, 2025

Read More ›

Hologic Completes Acquisition of Gynesonics, Inc.

January 6, 2025

Read More ›

HistoSonics Edison® Histotripsy System Treats First Pancreatic Tumor Patients in GANNON Trial

December 16, 2024

Read More ›

ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine

December 3, 2024

Read More ›

Contego Medical’s Neuroguard IEP System Receives FDA Approval for Carotid Revascularization

October 15, 2024

Read More ›

Hologic to Acquire Gynesonics, Developer of Minimally Invasive Solutions for Women’s Health

October 14, 2024

Read More ›

ShiraTronics Raises $66 Million in Oversubscribed Series B Financing to Advance Pioneering Treatment for Chronic Migraine

October 9, 2024

Read More ›

Twelve-Month Results from Landmark QUEST Study Published in Neuromodulation

September 26, 2024

Read More ›

Synergy Spine Solutions announces completion of patient enrollment in the Synergy Disc® 2-Level IDE clinical trial

September 25, 2024

Read More ›

© 2024 Amzak Health | Privacy Policy | Luxury Marketing Mediaboom

category

medtech

status

Current

headquarters

Plymouth, Minnesota

website

Visit Website ›

HistoSonics

HistoSonics has developed a system to destroy tumors completely non-invasively. Treatment is achieved using histotripsy, a novel form of energy that is safe, extremely precise, and able to be personalized for each patient. The initial indication is for treatment of liver tumors and the system is being studied in several other types of tumors.